System, device and method for high-throughput multi-plexed detection
US-9506917-B2 · Nov 29, 2016 · US
US10274486B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10274486-B2 |
| Application number | US-201615290874-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 11, 2016 |
| Priority date | Aug 24, 2012 |
| Publication date | Apr 30, 2019 |
| Grant date | Apr 30, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a system, device, and method for the high throughput multiplexed detection of a wide number of compounds. The invention comprises of a microwell array coupled to a capture agent array to form a plurality of interfaces between a microwell and a set of immobilized capture agents. The set of capture agents comprises a plurality of distinguishable features, with each feature corresponding to the detection of a particular compound of interest. In certain embodiments, each microwell is configured to contain a single cell. The invention is therefore capable of performing a high throughput analysis of single cell profiles, including profiles of secreted compounds.
Opening claim text (preview).
What is claimed: 1. A device for multiplexed detection of molecules produced from a cell, the device comprising: a plurality of enclosed interfaces, wherein each enclosed interface comprises (a) a substrate containing at least ten spatially identifiable isolated features, wherein of the at least ten of the isolated features, at least two isolated features contain at least two immobilized capture antibodies per isolated feature, and wherein each immobilized capture antibody specifically recognizes a different protein of interest, and (b) a chamber configured to contain a cell and the at least ten spatially identifiable isolated features of (a). 2. The device of claim 1 , wherein the chamber is a rectangle. 3. The device of claim 1 , wherein the chamber is a microchamber. 4. The device of claim 1 , wherein each isolated feature is separated from the next isolated feature by about 2-50 μm. 5. The device of claim 1 , wherein the isolated features are arrayed with a pitch size of 50 μm. 6. The device of claim 1 , wherein each isolated feature is 2-100 μm in width. 7. The device of claim 1 , wherein the enclosed interfaces are arranged in an array format including parallel lines or dots. 8. The device of claim 1 , wherein the isolated features are arranged in parallel within the enclosed interfaces. 9. The device of claim 3 , wherein the device comprises 200 microchambers per cm 2 to 20,000 microchambers per cm 2 . 10. The device of claim 3 , wherein the device comprises 100 microchambers to 100,000 microchambers. 11. The device of claim 3 , wherein each microchamber has a length of 10 μm to 2000 μm, a width of 10 μm to 100 μm, and a depth of 10 μm to 100 μm. 12. The device of claim 1 , wherein each of the isolated features contains at least three immobilized capture antibodies. 13. The device of claim 1 , wherein the isolated features are fabricated by a micro-scale printing technique. 14. The device of claim 13 , wherein the micro-scale printing technique is microspotting or inkjet printing. 15. The device of claim 1 , wherein the device comprises at least one cell within a chamber of at least one enclosed interface. 16. The device of claim 1 , wherein the chamber comprises proteins secreted from the at least one cell. 17. The device of claim 16 , wherein the proteins bind to one or more capture antibodies of at least one isolated feature of the substrate.
Cancer · CPC title
Apparatus specially adapted for solid-phase testing · CPC title
Solid-phase reaction mechanisms · CPC title
Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes · CPC title
Analytical elements · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.